Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 2500.00 | 469.42 | 10750.00 | 10871.50 | 0.9890 | 0.9951 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 469.42 | 6060.33 | 10871.50 | 0.5565 | 0.7555 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 2500.00 | 469.42 | 1502.67 | 10871.50 | 0.1364 | 0.2600 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 469.42 | 1156.67 | 10871.50 | 0.1065 | 0.2154 |
| MCF 10A | Erlotinib | 10 | uM | 7 | 2500.00 | 469.42 | 1241.00 | 10871.50 | 0.1144 | 0.2393 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 469.42 | 1077.00 | 10871.50 | 0.0988 | 0.1993 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 370.81 | 10348.67 | 10569.25 | 0.9792 | 0.9913 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 5000.00 | 370.81 | 10009.67 | 10569.25 | 0.9472 | 0.9777 |
| MCF 10A | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 370.81 | 10166.33 | 10569.25 | 0.9618 | 0.9840 |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 5000.00 | 370.81 | 10005.00 | 10569.25 | 0.9468 | 0.9775 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 370.81 | 7745.67 | 10569.25 | 0.7329 | 0.8755 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 5000.00 | 370.81 | 4617.33 | 10569.25 | 0.4378 | 0.6829 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 370.81 | 4241.00 | 10569.25 | 0.4016 | 0.6554 |
| MCF 10A | Erlotinib | 10 | uM | 7 | 5000.00 | 370.81 | 4209.67 | 10569.25 | 0.3987 | 0.6525 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 370.81 | 3934.00 | 10569.25 | 0.3722 | 0.6300 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 33.46 | 111.33 | 98.67 | 1.1325 | 1.1600 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 156.25 | 33.46 | 139.33 | 98.67 | 1.4156 | 1.4973 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 99.67 | 98.67 | 1.0137 | 1.0112 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 156.25 | 33.46 | 111.33 | 98.67 | 1.1333 | 1.1574 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 126.67 | 98.67 | 1.2831 | 1.3421 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 156.25 | 33.46 | 101.00 | 98.67 | 1.0264 | 1.0321 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 85.33 | 98.67 | 0.8633 | 0.8147 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 156.25 | 33.46 | 79.33 | 98.67 | 0.8034 | 0.7333 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 143.33 | 98.67 | 1.4471 | 1.4797 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 262.33 | 265.67 | 0.9771 | 0.8768 |